What is the Impact Factor of Breast Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Breast Cancer is 3.70, ranking in quartile Q1 of Web of Science (SCIE).

Is Breast Cancer indexed in Web of Science or Scopus?

Yes, Breast Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.036 (Q1) and an H-index of 72.

Who publishes Breast Cancer and what is the Article Processing Charge (APC)?

Breast Cancer is published by Springer Japan. The estimated Article Processing Charge (APC) is approximately $3,305 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Breast Cancer?

The official ISO-4 abbreviation of Breast Cancer is "BREAST CANCER-TOKYO" with common acronym "brca". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #4,616Hybrid

Breast Cancer

Acronym:brca

•

Abbreviation (ISO):BREAST CANCER-TOKYO

•

Identifier (ISSN):1340-6868(Print)/1880-4233(Online)

•

Publisher:Springer Japan

Official Website Submission Portal Compare

Clarivate IF (2026)

3.7↑ +0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Breast Cancer

WoS Q1

Annual Impact Factor Metric

Current (2026):3.7

Scopus SJR & RankScopus Q1

1.036

#4,616

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

72 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate2.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

106articles/year

41.55% Gold OA•86.41% Original Research

Aims & Scope

Breast Cancer, the official journal of the Japanese Breast Cancer Society, publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research, seeking to develop a new focus and new perspectives for all who are concerned with breast cancer. The journal welcomes all original articles describing clinical and epidemiological studies and laboratory investigations regarding breast cancer and related diseases. The journal will consider five types of articles: editorials, review articles, original articles, case reports, and rapid communications. Although editorials and review articles will principally be solicited by the editors, they can also be submitted for peer review, as in the case of original articles. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.

Topics Covered (Recognized by AI)

Medicine99.7%Internal medicine99.5%Biology97%Genetics96.7%Cancer96.1%Breast cancer94.1%Surgery81%Oncology77.5%Surgical oncology65.6%Pathology63%Radiology38.1%Chemistry29.5%Immunology26.1%Biochemistry25.9%Mathematics20.7%

Primary Research Areas

Oncology Obstetrics & Gynecology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

OBSTETRICS & GYNECOLOGY

Rank21/143

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank129/333

IndexSCIE

JCISCIE2026

OBSTETRICS & GYNECOLOGY

Rank36/143

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank91/333

IndexSCIE

Category	Index	Rank	Quartile
OBSTETRICS & GYNECOLOGY	JCRSCIE	21/143	Q1
ONCOLOGY	JCRSCIE	129/333	Q2
OBSTETRICS & GYNECOLOGY	JCISCIE	36/143	Q2
ONCOLOGY	JCISCIE	91/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.7

Articles / Year146

Total Citations26

2025

IF2.9

Articles / Year148

Total Citations257

2024

IF4

Articles / Year155

Total Citations1,004

2023

IF4

Articles / Year108

Total Citations861

2022

IF3.307

Articles / Year159

Total Citations1,981

Year	Impact Factor	Articles / Year	Total Citations
2026	3.7	146	26
2025	2.9	148	257
2024	4	155	1,004
2023	4	108	861
2022	3.307	159	1,981
2021	4.239	149	2,181
2020	2.695	155	3,776
2019	2.044	98	2,460
2018	1.772	138	2,800
2017	—	164	3,013
2016	—	96	2,494
2015	—	96	2,207

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,616Scopus Q1SCImago Profile

Scopus Coverage:1994-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.036

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.48

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,305 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,149

3-Year Documents331

Citable Documents318

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate40.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

Pharmacology (medical)Q1

Radiology, Nuclear Medicine and ImagingQ1

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Breast Cancer (acronym: brca, abbr: BREAST CANCER-TOKYO, ISSN: 1340-6868) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer Japan in Japan since 1994. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.036 (Q1), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 106 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,305 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.